GlassScriptPhysician profile
Jonathan M Kwong
NPI 1376868166
$2,397.07
in general payments reported to CMS, 2019-2025
12 companies · $973 in 2025
The $973 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $971 · 2024: $453 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $971.31 | 2022 | |
| Bolton Medical INC | $505.89 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Surmodics, INC. | $186.98 | 2025 | Pounce Thrombectomy, Pounce LP Thrombectomy, Pounce Xl Thrombectomy |
| W. L. Gore & Associates, INC. | $154.43 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $127.71 | 2025 | Heli-Fx Endoanchor System |
| Contego Medical, INC | $121.63 | 2024 | |
| Baxter Healthcare | $118.77 | 2025 | Tisseel |
| Cook Medical LLC | $86.25 | 2025 | Zenith |
| Kerecis Limited | $57.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medical Device Business Services, INC. | $27.79 | 2025 | Harmonic |
| Organogenesis INC. | $19.75 | 2025 | Puraply Wound Matrix |
| Bridgebio Pharma, INC. | $19.34 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kwong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.